Neurodegenerative disease is a kind of chronic, progressive nervous system disease
characterized by neuron degeneration or apoptosis. Current treatments cannot prevent the …

Over the past few decades, the application of mesenchymal stem cells has captured the
attention of researchers and practitioners worldwide. These cells can be obtained from …

Parkinson's disease (PD) has become the second largest neurodegenerative disease after
Alzheimer's disease, and its incidence is increasing year by year. Traditional dopamine …

Parkinson's disease is characterized by the loss of dopaminergic neurons in the substantia
nigra pars compacta, and although restoring striatal dopamine levels may improve …

Neurodegenerative disorders are characterized by the gradual decline and irreversible loss
of cognitive functions and CNS structures. As therapeutic recourse stagnates …

Parkinson's disease (PD) is a complex neurodegenerative disease in which the
understanding of the underlying molecular mechanisms can be constructive in the diagnosis …

Lysosomal storage diseases (LSDs) are a group of approximately 50 genetic disorders
caused by mutations in genes coding enzymes that are involved in cell degradation and …

Exosomes are nanovesicles with multiple components used in several applications.
Mesenchymal stem cells (MSCs) are well known for their great potential in clinical …

Background and aim Parkinson's disease (PD) is a progressive neurodegenerative disorder
caused by the destruction of the dopaminergic neurons in the nigrostriatal pathway, leading …

Spinocerebellar ataxia (SCA) is a heterogeneous disorder characterized by impaired
balance and coordination caused by cerebellar dysfunction. The absence of treatments …